Inga Schulte
About Inga Schulte
Inga Schulte is a Senior Cell Therapy Site Manager at Bristol Myers Squibb, with over 17 years of experience in the pharmaceutical and biotechnology industry, specializing in oncology and cell therapy.
Current Role at Bristol Myers Squibb
Inga Schulte serves as a Senior Cell Therapy Site Manager (CAR T) at Bristol Myers Squibb. She transitioned to this role in 2021, bringing extensive experience in the field of cell therapy and oncology. Her current responsibilities likely involve managing CAR T cell therapy projects, collaborating with healthcare providers and researchers, and potentially engaging in patient safety programs and risk management strategies. Her work could also include efforts to improve patient access to medications and promote health equity.
Previous Experience at Celgene
Before joining Bristol Myers Squibb, Inga Schulte worked at Celgene from 2015 to 2021. She held the position of Senior Cell Therapy Site Manager from 2019 to 2021, focusing on cell therapy initiatives in Nord-West. Prior to that, she spent four years as a Hämato-Onkologische Fachreferentin, contributing to Celgene's oncology strategies. Her tenure at Celgene highlights her commitment to advancing cell therapy and her expertise in oncology.
Broad Experience in Oncology
Inga Schulte has over 17 years of experience in the pharmaceutical and biotechnology industry, with a significant focus on oncology. She has held various oncology-related roles at companies such as Celgene, PharmaMar, and AstraZeneca. Her work has included positions as a Key Account Manager Oncology and Fachaußendienst Onkologie, where she developed a deep understanding of cancer treatment and management.
Educational Background and Early Career
Inga Schulte studied at Heinrich-Heine-Universität Düsseldorf, earning a Diplom in Biologie, allgemein in 2003. Her early career involved significant roles at AstraZeneca, including Fachaußendienst ZNS, where she worked on Central Nervous System disorders from 2004 to 2007, and Fachaußendienst Onkologie from 2007 to 2009. She further expanded her expertise in oncology as a Key Account Manager Internistische Onkologie from 2009 to 2010.
Key Account Management and Product Management Roles
Throughout her career, Inga Schulte has held various managerial and specialist roles, particularly in key account management and product management. She worked as a Product Manager at Swedish Orphan Biovitrum AB (Sobi) from 2010 to 2013 and as a Key Account Manager Oncology at PharmaMar from 2013 to 2015. These roles have equipped her with the skills to manage complex projects and build strong relationships with key stakeholders in the pharmaceutical industry.